BIOMAT Database Logo BIOMAT Database Logo

[Plasma desipramine levels and clinical response in patients with major depression. Results in agreement with a curvilinear relationship]. 1989

G Bertschy, and S Vandel, and B Vandel, and G Allers, and P Bechtel

UI MeSH Term Description Entries
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D003891 Desipramine A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. Desmethylimipramine,Apo-Desipramine,Demethylimipramine,Desipramine Hydrochloride,Norpramin,Novo-Desipramine,Nu-Desipramine,PMS-Desipramine,Pertofran,Pertofrane,Pertrofran,Petylyl,Ratio-Desipramine,Apo Desipramine,Hydrochloride, Desipramine,Novo Desipramine,Nu Desipramine,PMS Desipramine,Ratio Desipramine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Bertschy, and S Vandel, and B Vandel, and G Allers, and P Bechtel
Desipramine plasma levels and clinical response: evidence for a curvilinear relationship.
June 1987, Journal of clinical psychopharmacology,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and P Bechtel
Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study.
January 1997, European journal of clinical pharmacology,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and P Bechtel
Relationship between tricyclic antidepressant plasma levels and clinical response in patients treated with desipramine or doxepin.
June 1983, Acta psychiatrica Scandinavica,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and P Bechtel
Relationship between plasma desipramine levels and clinical outcome for RDC major depressive inpatients.
January 1983, Psychopharmacology,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and P Bechtel
Desipramine does not alter plasma GABA in patients with major depression.
September 1993, Journal of affective disorders,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and P Bechtel
Clinical response, plasma levels and pharmacokinetics of desipramine in depressed in-patients.
January 1980, Progress in neuro-psychopharmacology,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and P Bechtel
Desipramine plasma levels and clinical response in depressed outpatients.
January 1979, Communications in psychopharmacology,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and P Bechtel
Desipramine plasma levels and response in elderly melancholic patients.
August 1985, Journal of clinical psychopharmacology,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and P Bechtel
High dose desipramine, plasma drug levels and clinical response.
March 1979, The Journal of clinical psychiatry,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and P Bechtel
Desipramine plasma levels and therapeutic response.
January 1978, Psychopharmacology bulletin,
Copied contents to your clipboard!